Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 20Lymphoma 5Neoplasms, Plasma Cell 4Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Smoldering Multiple Myeloma 1Sarcoma 1Paraproteinemias 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Disease 1Carcinoma 1Amyloidosis 1Alzheimer Disease 1

Interventions

Dexamethasone 4selinexor 1pomalidomide 1ixazomib 1birtamimab 1Positron-Emission Tomography 1Melphalan 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alzheimer Disease × Blood Specimen Collection × Plasma cell × Clear all
NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Samus Therapeutics, Inc.

Phase EARLY_PHASE1 Terminated
5 enrolled
LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡